Respirent Pharmaceuticals Co.,Ltd. – Trademark Portfolio

Entity Type: 16

Respirent Pharmaceuticals Co.,Ltd. has 48 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO). The portfolio includes 0 registered trademarks and 2 pending applications. Filings span 3 Nice Classification classes, led by Class 5 (Pharmaceuticals) and Class 10 (Medical Apparatus). This trademark owner is based in Chongqing.

5-190,Yunhan Drive, High-tech

Industrial Park,Shuitu,Beibei District,

Chongqing 400714 , CN

48 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Page 1 of 2 (48 results)

Trademark Classifications

Respirent Pharmaceuticals Co.,Ltd.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (20 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (19 filings)

Surgical, medical, dental and veterinary apparatus and instruments

35
Advertising & Business (13 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does Respirent Pharmaceuticals Co.,Ltd. have?

Respirent Pharmaceuticals Co.,Ltd. has 48 U.S. trademarks filed with the USPTO. Of these, 2 pending, 40 abandoned, 6 cancelled.

What trademark classes does Respirent Pharmaceuticals Co.,Ltd. file in?

Respirent Pharmaceuticals Co.,Ltd. files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 35 (Advertising & Business). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What is Respirent Pharmaceuticals Co.,Ltd.'s trademark registration success rate?

Respirent Pharmaceuticals Co.,Ltd. has a 0% trademark registration rate, with 0 out of 46 resolved applications resulting in successful registration. Currently, 2 applications are pending review.